Vaginal Changes and Sexuality in Women with a History of Cervical Cancer
K. Bergmark and Others
Abramson Cancer Center of the University of Pennsylvania
Last Modified: November 1, 2001
Reviewers: Kenneth Blank, MD
Source: New England Journal of Medicine, May 6, 1999 Vol. 340 No. 18 p. 1383
Local treatment of cervical cancer often involves surgery, radiotherapy, or a combination of both treatments. For early stage cervical cancer, these treatments are very effective, curing the majority of women. Unfortunately, side effects can result from both surgery and radiotherapy. The adverse effects of these treatments on women's sexual functioning have been recognized but rarely studied. Inthe May 6, 1999 New England Journal of Medicine, a report from Sweden thoroughly examines adverse treatment effects on women's sexual functioning.
Three hundred thirty two women with stage IB or IIA cervical cancer were invited to participate in the study. They were matched to a control group of 489 women of similar age and region of residence, who were without cervical cancer. Of the 821 women in total, 708 agreed to participate in the study and were sent a questionnaire about their sexual functioning and vaginal changes. The questionnaire was designed to assess for sexual dysfunction with attention to sexual arousal, painful intercourse, and orgasmic pleasure.
Of women with cervical cancer in this study, 52% were treated with surgery and radiotherapy (external beam, brachytherapy or both), and 36% were treated with surgery alone.
Twenty-six percent of women treated for cervical cancer reported that vaginal lubrication during intercourse was compromised significantly compared to 11% of women in the control group. Women treated for cervical cancer also reported other indicators of sexual dysfunction more often, such as vaginal shortness and vaginal elasticity, than women in the control group. Of women who reported vaginal changes, these changes caused distress for twice as many women treated for cervical cancer as controls. Approximately 10% of women treated for cervical cancer reported intercourse to be painful compared to approximately 3% of women in the control group. The frequency and pleasure of orgasm was similar in both groups.
Analysis by treatment received for cervical cancer revealed that surgery was associated with vaginal shortening, insufficient vaginal lubrication, and reduced vaginal elasticity. When compared to surgery alone, the addition of external beam, intracavity radiotherapy or both did not affect the frequency of sexual dysfunction.
Women undergoing treatment for early stage cervical cancer develop significant vaginal changes, which are associated with sexual dysfunction. Gynecologists and radiation oncologists must be aware of these side effects, and they are encouraged to have frank discussions with their patients about the body changes that occur after surgery and radiotherapy.
ACOG recommends cytology screening start at age 21 regardless of the onset of sexual activity
Jul 23, 2010 - Although prior recommendations of major societies advised cervical cytology screening in adolescents based on onset of vaginal intercourse, the American College of Obstetricians and Gynecologists now recommends that screening begin at age 21, regardless of sexual activity, due to the rarity of cervical cancer in women under 21. These recommendations have been published in the August issue of Obstetrics & Gynecology.
Frequently Asked Questions
National Cancer Institute
I Wish You Knew
How cancer patients have changed my life
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!